middle.news

Bio-Gene Unveils 95M Placement Options Ahead of July Shareholder Vote

7:01am on Saturday 12th of July, 2025 AEST Biotechnology
Read Story

Bio-Gene Unveils 95M Placement Options Ahead of July Shareholder Vote

7:01am on Saturday 12th of July, 2025 AEST
Key Points
  • Offer of 95,352,788 Placement Options split equally between 2028 and 2030 expiry dates
  • Exercise prices set at 3.4 cents (2028 Options) and 4.6 cents (2030 Options)
  • Grant of options conditional on shareholder approval at 14 July 2025 EGM
  • Options issued for no cash consideration, not quoted on ASX
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Bio-Gene Technology (ASX:BGT)
OPEN ARTICLE